Brief: Igea Pharma Says Miami University Confirms 'High Quality' Of Igea's COVID-19 Rapid Test

IGEA Pharma NV

06/05/2020 04:05

May 5 (Reuters) - IGEA Pharma NV  IGPH.S :
    * MIAMI UNIVERSITY CONFIRMS HIGH QUALITY OF IGEA'S COVID-19
RAPID
TEST
    * EVALUATION BY UNIVERSITY OF MIAMI SUGGESTS IGEA'S COVID-19
ANTIBODY RAPID TEST APPEARS TO BE SUPERIOR IN DETECTING IGM AND
IGG ANTIBODIES
    * OVERALL HIGHER SENSITIVITY OF IGEA'S RAPID TEST OVER ELISA
PROCEDURE USED OBSERVED USING RT PCR TEST COMPARISON FOR SAME
SPECIMENS
    * PCR RESULTS COMPARISON COULD SUGGEST SUITABILITY IN USING
ANTIBODY-BASED TEST EVEN IN EARLY STAGES OF INFECTION

Source text for Eikon:  ID:nEQ91464fa 
Further company coverage:  IGPH.S 

 ((Reuters.Briefs@thomsonreuters.com;))